APDN - APPLIED DNA SCIENCES INC
IEX Last Trade
0.1842
-0.007 -3.963%
Share volume: 6,586
Last Updated: Fri 27 Dec 2024 08:29:22 PM CET
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.90%
PREVIOUS CLOSE
CHG
CHG%
$0.19
-0.01
-3.81%
Fundamental analysis
26%
Profitability
27%
Dept financing
16%
Liquidity
75%
Performance
15%
Performance
5 Days
7.32%
1 Month
15.43%
3 Months
-80.74%
6 Months
-56.39%
1 Year
-98.56%
2 Year
-99.30%
Key data
Stock price
$0.18
DAY RANGE
$0.18 - $0.19
52 WEEK RANGE
$0.15 - $14.40
52 WEEK CHANGE
-$98.55
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
12/05/2024
Company detail
CEO: James A. Hayward
Region: US
Website: adnas.com
Employees: 70
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: adnas.com
Employees: 70
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
Applied DNA Sciences, Inc. develops and markets DNA-based technology solutions for use in the nucleic acid-based in vitro diagnostics and preclinical nucleic-acid based drug development and manufacturing markets. The company's supply chain security and product authentication solutions include SigNature molecular tags that provide forensic power and protection for various applications used to fortify brand protection efforts.
Recent news